Microvast Holdings announces departure of chief financial officer
Investing.com -- Procter & Gamble (NYSE:PG) shares fell about 4% today following comments from BNP Paribas (OTC:BNPQY) analyst Kevin Grundy, who expressed skepticism about the company's fiscal 2025 organic sales guidance.
Grundy's caution comes amid heightened short-term market uncertainty in the United States, which could impact Procter & Gamble's performance.
The analyst's note, published after a February 13 meeting with P&G executive and CEO Jon Moeller, highlighted the current volatility in the market.
Moeller acknowledged that short-term volatility is "probably higher today" than at any point he can recall. Specific challenges noted by P&G include signs of slowing in their categories within the US and retailer de-stocking.
Despite these challenges, Procter & Gamble maintains that it has "ample" flexibility in its profit and loss to protect earnings per share (EPS) if organic sales growth were to slow down.
The company also reported that its business in Europe remains "very strong" and that Latin America is "super strong." However, the situation in China remains uncertain, with the company stating it is "still too early... but not taking off."
BNP Paribas highlighted the concerns by stating, "guidance seens ti be 'very likely to be off the table,' due to near-term uncertainty in the US market."
This comment has added to investor worries, leading to today's decline in the company's stock price.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.